Bajjoka I - Search Results

1

YSPSL (rPSGL-Ig) for improvement of early renal allograft function: a double-blind, placebo-controlled, multi-center Phase IIa study.

Gaber AO, Mulgaonkar S, Kahan BD, Woodle ES, Alloway R, Bajjoka I, Jensik S, Klintmalm GB, Patton PR, Wiseman A, Lipshutz G, Kupiec-Weglinski J, Gaber LW, Katz E, Irish W, Squiers EC, Hemmerich S. Gaber AO, et al. Among authors: bajjoka i. Clin Transplant. 2011 Jul-Aug;25(4):523-33. doi: 10.1111/j.1399-0012.2010.01295.x. Epub 2010 Jun 22. Clin Transplant. 2011. PMID: 20573162 Clinical Trial.

2

Preserving renal function in liver transplant recipients with rabbit anti-thymocyte globulin and delayed initiation of calcineurin inhibitors.

Bajjoka I, Hsaiky L, Brown K, Abouljoud M. Bajjoka I, et al. Liver Transpl. 2008 Jan;14(1):66-72. doi: 10.1002/lt.21309. Liver Transpl. 2008. PMID: 18161842 Free article.

3

The efficacy and limitations of sirolimus conversion in liver transplant patients who develop renal dysfunction on calcineurin inhibitors.

Lam P, Yoshida A, Brown K, Abouljoud M, Bajjoka I, Dagher F, Moonka DK. Lam P, et al. Among authors: bajjoka i. Dig Dis Sci. 2004 Jun;49(6):1029-35. doi: 10.1023/b:ddas.0000034567.53748.df. Dig Dis Sci. 2004. PMID: 15309896 Clinical Trial.

4

Proposed relationship between intravenous immunoglobulin and thrombosis in renal transplant recipients.

Duronio A, Bajjoka I, Hsaiky L, Parasuraman R. Duronio A, et al. Among authors: bajjoka i. Ann Pharmacother. 2007 Feb;41(2):354-8. doi: 10.1345/aph.1H434. Epub 2007 Jan 30. Ann Pharmacother. 2007. PMID: 17264157

5

Recurrent disease after liver transplantation.

Abouljoud MS, Escobar F, Douzdjian V, Bajjoka I, Moonka D, Shick L, Brown KA. Abouljoud MS, et al. Among authors: bajjoka i. Transplant Proc. 2001 Aug;33(5):2716-9. doi: 10.1016/s0041-1345(01)02159-5. Transplant Proc. 2001. PMID: 11498137 Review. No abstract available.

6

Clostridium difficile infection in liver transplant recipients: a retrospective study of rates, risk factors and outcomes.

Mittal C, Hassan S, Arshad S, Jeepalyam S, Bruni S, Miceli M, Jacobsen G, Abouljoud M, Bajjoka I, Ramesh M, Alangaden G. Mittal C, et al. Among authors: bajjoka i. Am J Transplant. 2014 Aug;14(8):1901-7. doi: 10.1111/ajt.12798. Epub 2014 Jun 5. Am J Transplant. 2014. PMID: 24902610 Free article.

7

Combination antifungal therapy for invasive aspergillosis infection in liver transplant recipients: report of two patients.

Bajjoka IE, Bailey EM, Vazquez JA, Abouljoud MS. Bajjoka IE, et al. Pharmacotherapy. 1999 Jan;19(1):118-23. doi: 10.1592/phco.19.1.118.30511. Pharmacotherapy. 1999. PMID: 9917086

8

Tenofovir-emtricitabine therapy for the prevention of hepatitis B recurrence in four patients after liver transplantation.

McGonigal KH, Bajjoka IE, Abouljoud MS. McGonigal KH, et al. Among authors: bajjoka ie. Pharmacotherapy. 2013 Sep;33(9):e170-6. doi: 10.1002/phar.1306. Epub 2013 Jun 6. Pharmacotherapy. 2013. PMID: 23744810

9

Treatment options for osteoporosis in chronic liver disease patients requiring liver transplantation.

Ng TM, Bajjoka IE. Ng TM, et al. Among authors: bajjoka ie. Ann Pharmacother. 1999 Feb;33(2):233-5. doi: 10.1345/aph.17405. Ann Pharmacother. 1999. PMID: 10084420 Review.

10

Candida kefyr, an uncommon but emerging fungal pathogen: report of two cases.

Corpus K, Hegeman-Dingle R, Bajjoka I. Corpus K, et al. Among authors: bajjoka i. Pharmacotherapy. 2004 Aug;24(8):1084-8. doi: 10.1592/phco.24.11.1084.36140. Pharmacotherapy. 2004. PMID: 15338856

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page